Lloyd Kelly E, Wilson Caroline, Carrie Sean, Rooshenas Leila, Wilson Janet A, Hamilton David, Clark Emma, Rousseau Nikki
Leeds Institute of Health Sciences, University of Leeds, Leeds, UK
Northern Ireland Clinical Trials, Belfast, UK.
BMJ Open. 2025 Jun 8;15(6):e099395. doi: 10.1136/bmjopen-2025-099395.
To understand healthcare professionals' and patients' views and experiences of septoplasty and medical management (ie, nasal steroid and saline sprays) for nasal obstruction.
Nested qualitative study as part of the Nasal Airway Obstruction Study (NAIROS) trial. We used in-depth interviews to develop a coding framework based on thematic analysis.
NAIROS was a trial based in the UK from January 2018 to December 2020 that aimed to compare the effectiveness of septoplasty versus medical management.
We purposively sampled and interviewed 14 healthcare professionals (surgeons, research nurses) and 31 patients involved in the NAIROS trial across 14 UK hospital sites.
In usual practice, surgeons' decisions regarding treatment for nasal obstruction are based on a complex assessment of patients' symptoms, history and anatomy. Surgeons viewed septoplasty as a complex although routine operation, which is not guaranteed to improve symptoms of nasal obstruction. Some patients saw septoplasty, intuitively, as a 'fix' for a bent septum, whereas others were keen to avoid surgery if possible. Healthcare professionals welcomed the increased use of standard measurements if these were shown to provide a reliable guide to patient outcomes. However, they felt that it was important to retain an element of clinical judgement. Despite generally good outcomes from septoplasty, some patients still felt they had received little to no benefit from the operation. Patients also reported being underprepared for postsurgery recovery. Experiences were more varied with medical management, with some experiencing symptom improvement, but others discontinuing treatment due to difficulty or pain using the sprays, or perceived ineffectiveness. Remembering to use the sprays could be perceived as burdensome, although most patients were able to incorporate this into their daily routines.
Our qualitative study demonstrated varied individual experiences among patients undergoing septoplasty and medical management. Surgeons welcomed more standard measurements to guide decision-making for septoplasty. For patients, better information about treatment mechanisms, treatment delivery and aftercare, and the development of decision support tools would enable shared decision-making and help to provide optimal patient experience of the treatments.
ISRCTN16168569.
了解医疗保健专业人员和患者对于鼻中隔成形术及药物治疗(即使用鼻用类固醇和盐水喷雾剂)治疗鼻塞的看法和体验。
作为鼻腔气道阻塞研究(NAIROS)试验一部分的嵌套式定性研究。我们采用深入访谈,基于主题分析制定编码框架。
NAIROS是一项于2018年1月至2020年12月在英国开展的试验,旨在比较鼻中隔成形术与药物治疗的有效性。
我们有目的地选取并访谈了参与NAIROS试验的14名医疗保健专业人员(外科医生、研究护士)和31名患者,这些人员来自英国14个医院站点。
在常规实践中,外科医生对于鼻塞治疗的决策基于对患者症状、病史和解剖结构的综合评估。外科医生认为鼻中隔成形术虽是一项常规但复杂的手术,不能保证改善鼻塞症状。一些患者直观地将鼻中隔成形术视为矫正鼻中隔偏曲的“解决方案”,而另一些患者则尽可能避免手术。如果标准测量结果能为患者预后提供可靠指导,医疗保健专业人员欢迎更多地使用这些测量方法。然而,他们认为保留一定的临床判断力很重要。尽管鼻中隔成形术总体效果良好,但一些患者仍觉得手术对他们几乎没有益处或毫无益处。患者还表示对术后恢复准备不足。药物治疗的体验则更为多样,一些患者症状有所改善,但另一些患者因使用喷雾剂困难或疼痛,或认为无效而停止治疗。尽管大多数患者能够将使用喷雾剂纳入日常生活,但记住使用喷雾剂可能会被视为负担。
我们的定性研究表明,接受鼻中隔成形术和药物治疗的患者个体体验各不相同。外科医生欢迎更多标准测量方法来指导鼻中隔成形术的决策。对于患者而言,提供更多关于治疗机制、治疗实施和术后护理的信息,以及开发决策支持工具,将有助于共同决策,并为患者提供最佳治疗体验。
ISRCTN16168569。